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Studies were made to determine factors important in 
the phototoxicity mechanism of 7 clinically used tetra-
cyclines (TC). The clinical phototoxicity, the rates of 
photochemical degradation, and the in vitro phototox-
icity of the TCs were qualitatively but not quantitatively 
correlated. Phototoxicity in vitro was partially oxygen-
dependent and possibly singlet oxygen is involved. The 
contribution of photoproducts to the phototoxic process 
may be the basis for the reported differences between 
the in vivo action spectrum and the absorption spectrum 
of demethylchlorotetracycline. A mechanistic model for 
in v ivo phototoxicity is proposed where the absorption 
of UV A r a diation by TC leads to at least two main 
processes: (i) photosensitization by the drug of biologic 
m olecules to cause phototoxicity; (ii) production of one 
or more photoproducts which photosensitize b y absorp-
tion of visible radiation. 
The incidence of photosens it ivi ty reactions to the tetracy-
cline (TC) antibiotics varies wit h the structure of t he drug. 
From clinica l reports , demeclocycline (DMCT; 6-demethyl- 7-
chlorotetracycline} app ears to be t he m ost phototoxic. O t her 
TCs are infrequently reported to be phototoxic [1-7]. No re-
ports of phototox icity from minocycline (MC; 6-demethyl-6-
deoxy-7-dimethy lamin otetracycl ine) have appeared. The com -
mon manifestations ofTC photosens itivity a re a tingling, burn-
ing sensation [1 - 7], onycholysis [5 ,6], papular erupt ion (3] and, 
in o n e case, t he presence of mul t inucleated gian t ce lls [4 ]. The 
effective wavelengths for eliciting phototoxicity in v ivo a re 
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Abbreviations: 
AHTC: 5a,6-anhydrotetracycline 
BSA: bovine serum albumin 
CTC: (ch lortetracycline) 7-chlorotetracycl ine 
D 2 0 : deute rated water 
Dl\1CT: (demeclocycline) 6-demethyl-7-chlorotetracycl ine 
DOTC: (doxycycline) 6a-deoxy-5a-hydroxytetracycline 
HBSS: Hanks' buffered salt solu tion 
HSA: human serum albumin 
MC: (minocycline) 6-demet.hyl-6-deoxy-7 -dimethylaminotetra-
cycline 
MTC: (methacycline) 6-demethyl-6-deoxy-5-hydroxy-6-methyl-
en etetracycline 
OTC: (oxytetracycl ine) 5a-hydroxytetracycline 
PBMNC: peripheral blood mononuclear cells 
PBS: phosphate-buffered saline 
PHA: phytohemagglutinin 
PhTC: tetracycline photoproducts 
PTD60: dose of UVA required to reduce [3H]thymidine incorpo-
ration to 50% of that in unirradiated contro ls 
PVD60: dose of UVA required to reduce the number of viable cells 
to 50% of t he number in unirradiated cul tures 
TC: tetracycline 
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between 320-425 nm [2,7]. H owever, t he most effective wave-
length for DMCT photosensitization in a study with mice [8] 
was at 400 nm, rather than at the absorption maxima of the 
drug, 278 nm and 375 nm. 
T he mechanism of TC phototoxicity remains unknown. The 
available data indicate t hat t he cellular site for p hototox ic 
damage may be ribosomes and cell membranes. P hotoactivated 
TC covalently binds to both eukaryotic and prokaryotic ribo-
somes [9, 10] . TC has a lso been reported to cause photohemo-
lysis of huma n e rythrocytes by a n oxygen -independent mech -
a nism [11] . H owever, other s ites may be involved since, in t he 
da rk , TC interacts with other subcellular sites. For example, 
TC noncova len t ly binds to both DNA a nd human serum a lbu -
min (HSA} in t he presence of divalent cation s (12] and appears 
to affect DNA synthesis in Escherichia coli and Bacillus subtilis 
by inte racting with cell membrane [13]. Our overall goal is to 
elucidate t he molecula r mechanism ofTC phototoxicity. In t his 
ini tia l study we have: (1) evaluated the relationship between 
TC photodegradation rate, in v it ro phototoxicity, a nd clinical 
photosensitizing poten t ia l for 7 clinically used TCs, shown in 
T a ble I; (2) evaluated t he in vitro TC phototoxic ity to lym p ho-
cytes a nd t he involvement of oxidative mecha nisms and tetra-
cycline photoproduct(s) (PhTC} in th is process; and (3) pos-
t ulated a basis for the action spectrum. 
MATERIALS AND METHODS 
Tetracyclines 
The TC hydrochlorides were either purchased from Sigma or were 
generous gifts from Charles Pfizer Co., Groton, Connecticut, and Amer-
ican Cyanamid Company, Lederle Laboratories, Pearl River, New York. 
Anhydrotetracycline was prepared by the ac id-catalyzed dehydration 
of a methanol ic solut ion of TC [14] . 
I rra.diation Sources 
UVA irradiations were carried out using a 1.0 kW xenon arc lamp 
t hrough 10 em of circulating solution (4 % copper sulfate and 4% cobalt 
sulfate) which limited the irradiance to a 320- 400 nm waveband with 
a peak at 365 nm. The spectral irradiance of t his source (average output 
75 W /m2) was measured by a cosine-corrected UV spectroradiometer 
system (IL 700, International Light, Inc., Danvers, Massachusetts). A 
SEE 400 detector with a peak sensitivity at 360 nm and half-power 
points at 330 and 370 nm was used. For visible light irradiations (380-
600 nm) a 2500-W xenon arc source (Schoeffel Instruments) with an 
f/1.5 condensing lens system was used. For reactions with tetracycline 
(TC) and 5a-6-anhydrotetracycl ine (AHTC), radiation was filtered 
through a· 10% copper sulfate liquid filter, 3 pieces of 3/8-inch lucite, 
and a CS1-64 blue glass fil ter (Corning). The lucite filters sharply cut 
off wavelengths of less than 380 nm. The CS1-64 transmits maximally 
between approximate ly 380 and 420 nm and attenuates radiation of 
wavelengths above 500 nm. lrradiance was measured using an Eppley 
thermopile in conjunction with a Keithley 150B microvolt ammeter, 
and had an average output of 0.3 kW / m2 • For the phototoxicity assay 
with TC and PhTC, the CuSO,, liquid filter was replaced by water, and 
the CS1-64 blue glass filter was removed. The average output under 
these condi t ions was 0.7 kW/ m2• 
I n.strum.entation 
UV-visible absorption spectra were recorded using either a Varian 
DMS-90 or a Beckman 5270 spectrophotometer. Radioactivity meas-
urements were made on a Beckman LS 150 liquid scin tillation counter. 
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T ABLE I. Structure of tetracyclines 
Antibiotic Rl R. R, R, 
T C H CH" OH H 
CT C Cl CH" OH H 
OTC H CH" OH OH 
DOTC H CH" H OH 
DMCT Cl H OH H 
MTC H - -CH2-- OH 
MC N(CH:~), H H H 
0 .6 
WAVELENGTH (nm) 
FtG 1. Spect ral mon itoring of photodegradat ion of the T Cs with 
increasing UVA radiaton doses (0- 40 kJ / m2). (i ) init ial spectrum; (u ), 
(iii) , (iu), and (u) rep resent spectra afte r exposure to 5, 10, 20, and 40 
kJ / m2, respect ive ly, of irradiation. Experimental condit ions: T Cs (40-
60!JM) in HBSS were irradiated with a 1.0 kW xenon arc lamp set up 
to emit 320- 400 nm waveband irradiation. Spectra were recorded afte r 
exposure to t he varying doses of radiation. 
Photochemical Degradation Rates 
The TCs were dissolved in Hanks' buffe red salt solut ion (HBSS) at 
concent rations of 40- 60 J.lM , at pH 7.0. The solut ions were exposed to 
increasing UVA radiation doses (0- 40 kJ / m2) and their UV -visible 
spectra recorded after each irradiation (Fig 1). The rate of photodecom-
position was evaluated by monitoring the decrease in 365- 375 nm 
absorbance (Fig 2). For determining the effect of protein binding on 
T C photodegradation, BSA was dissolved in HBSS (2% w/vol) and 
these solut ions mixed wi th the drug solut ions such t hat the final 
concent rat ion of the TCs was again 40- 60 !JM and the bovine serum 
albumin (BSA) concent rat ion was about 1.2% w/vo l. Photolysis rate 
constants were evaluated as described. 
In Vitro Phototoxicity Assay 
T he in vit ro phototoxicity of the T Cs to lymphocytes was carried 
out essentially by the protocol reported by Morison et al [15]. Briefly, 
huma n peripheral blood mononuclear cells (PBMNC) were isolated on 
Ficoli -Hypaque gradients. These cells mixed wi th drugs (TCs or t heir 
P hTCs, typically at concent rations of 20 J.lg/ml) were incubated at 
37' C in an at mosphere of 5% C02 for 30 min. Samples were irradiated 
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FI G 2. First order plot of t he photodegradation of the T Cs in HBSS 
monito red by the decrease in the 365- 375 nm absorbance. A o is t he 
init ial absorbance; A , represents the absorbance at t ime t, and A m is 
the limiting value of A375 at complete photolysis. The slope of the line 
gives t he fi rst order rate constant. For the sake of clarity, plots for only 
4 of 7 compounds are presented. 
with 5 doses of UVA, 0.1- 8.0 x 104 J / m2, or with t he appropriate dose 
of visible light. (For visible irradiations, samples were cooled in ice.) 
Cells were t hen washed with equal volumes of HBSS and cent rifuged 
at 1200 rpm fo r 10 min . UV -visible spectra were then recorded for t he 
supernatant to determine the amount of T C photodestruction by mon-
itoring the absorbance at 360-375 nm. The pelleted cells were resus-
pended in complete medium with antibiotics and stimulated by t he 
addi t ion of 0.25 J.lg/culture of phytohemagglutinin (PHA) . After incu -
bation at 37' C in 5% C0 2 for 66 h, 0.5 J.lCi of ["H) thymidine was added , 
and t he incubation was cont inued for 6 h. The cells were then harvested 
using an automated harvester, and the radioactivi ty measured for each 
sample. The mean of t he radioactive counts per minute of the 3 samples 
fo r each condi tion was calculated. The method of least squares was 
then used to estimate the radiation dose required to reduce [3H ] 
thymidine incorporation to 50% of that in unirradiated cont rols. This 
dose is referred to as the 50% phototoxic dose or PTD50• The viability 
of t he PBMNC was determined by using the t rypan blue dye exclusion 
test . PBMN C cultured with PHA for 72 h after exposure to radiation 
and drug were harvested and redispersed wit h a Pasteur pipette. Im -
mediately following redispersion a 50-J.ll aliquot of cell suspension was 
mixed with 50 J.l l of 1% t rypan blue dye in saline, and cells t hat excluded 
the dye were considered to be viable. The dose of UV A radiation 
required to reduce the number of viable cells to 50% of the number in 
unirradiated cultures gave t he PVDso· 
Oxygen-Dependence Experiments 
In order to determine whether or not oxygen is required in t he rate-
determining step of the phototoxicity response, the lymphocyte pho-
totoxicity assay was perfo rmed Ln an oxygen-depleted atmosphere. 
Parallel sets of assays were run in which either N2 or air was bubbled 
through the samples (cells plus drugs) for 7 min immediately prior to 
irradiation. Subsequent workup and analyses were ident ical. The PTD50 
values under t he two experimental condit ions were compared. 
The involvement of singlet oxygen in the phototoxicity mechanism 
was evaluated by running parallel sets of lymphocyte phototoxicity 
assays in deute rated water (020) (Aldrich, 99.8 atom % D) and H20 . 
The PTDC>O in the two series of experiments were compared. 
RESULTS 
Photochemical Degradation of Tetracyclines 
Irradiation of T C solutions in HBSS equilibrated wit h air 
changed t heir electronic absorpt ion spectra, as shown in Fig 3. 
Typically, t he major peak in the 263- 268 nm region increased, 
the major peak in the 365- 375 nm region decreased, and a new 
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TABLE II. Comparison of the rate constants for the UVA -induced photodegradation of the tetracyclines with their effect on {'H) thymidine 
incorporation by PBMN cells 
Antibiotic" 102k, , min- 1 ± SO• lO'k', min-''± so• PTO .. , kJ/m2 ± so• PY060 
CT C 
DMCT 
DOTC 
T C 
OTC 
MTC 
MC 
11.0 ± 0.7 
9.6 ± 0.6 
8.7 ± 0.4 
7.0 ± 0.02 
6.8 ± 0.7 
6.6 ± 0.6 
0.21 ± 0.02 
17.9 ± 1.0 
22.7 ± 2.0 
9.5 ± 0.5 
2.58 ± 0.02 
n .d. 
11.6 
13.8 
5.3 
37 
45 
± 3.0 
± 6.0 
± 1.2 
± 3 
± 12 
25 
29 
n.d. 
n.d. 
46 
19 ± 0.9 
0. 21 >80 
25 
>80 
n.d. = not determined. 
o [TC ] = 5 x 10-• M; UV A irradiance = 75 W j m 2• 
b Numbers represent average values from at least 2 determinations. 
c Photolysis in t he presence of 1.2% BSA. 
0 .6 
Photo- DOTC 
400 500 600 
WAVELENGTH (nm) 
FIG 3. Comparison of t he change in the UV-visib le absorpt ion spec· 
t ra of DOTC and DMCT upon UV A irradiation. Experimental condi-
tions identical to those described for Fig L 
peak at wavelengths >400 nm appeared. The wavelength of 
maximum absorption for the new peak centered around 530 
nm for all the TCs, except the chlorinated compounds (CTC 
and DMCT) and MC. The major photoproduct under these 
conditions has been suggested to be a quinone [16] . Photolysis 
unde r reducing conditions (in the presence of {J- mercaptoeth-
anol), produced a new absorbance peak around 430 nm rather 
than at 530 nm [10]. The major photoproduct under these 
condi t ions is believed to be AHTC.* 
For CTC and DMCT the max imum absorption of the new 
peak is at 410 nm (Fig 3), indicating that different photoprod· 
ucts are formed from the ch lorinated tetracyclines. The MC 
absorption spectrum is unchanged even after extended photo· 
lyses (>200 kJ/m2) , indicating that MC is photostable. 
The rate of photodecomposition follows first order kinetics 
when monitored by the decrease in 365-375 nm absorbance 
(Fig 2). These rate constants (evaluated from the slope of the 
straight line in Fig 3) are presented in Table II for the photo-
decomposition in the presence and absence of added protein 
(BSA) . The salient resu lts are: (i) Photodegradation rate con-
stants vary by a factor of only 1.5 between the 6 TCs, excluding 
MC. The chloro-substituted TCs photodegraded the fastest; (ii) 
MC is photostable; (iii) The addition of BSA increases the rate 
* T . Hasan, M. Allen, B.S. Cooperman, manuscript in preparation. 
· ··· · · · · · · · ··'l(· · ····· · · · ··· · · ·· ············"'·· · ········-~·c; · ············ 
5 6 
UVA DOSE (kJ/M2) 
FIG 4. Effect of TC photosensitization upon PHA stimulation of 
lymphocytes. The PBMN cells were treated with drug and varying 
doses of UVA and the incorporation of [3H]t hymidine measured for 
each sample. The control was an unirradiated sample of cells t reated 
with drug. 
of photolysis of chlorotetracyclines (CTC and DMCT) but not 
that of the other T Cs. 
Phototoxicity of Tetracyclines to Lymphocytes 
The decrease in mitogen-stimulated incorporation of r 'H] 
thymidine by PBMNC after treatment with drug and varying 
doses of UV A is presented in Fig 4. The PTD50 values fo r 
reducing [aH]thymidine incorporation and cell viability are 
shown in Table II. All of the T Cs except MC are photosensitiz· 
ers. The PTD5o values varied by a factor of 8. This cont rasts 
with the factor of 1.5 determined for the relative photolysis 
ratio and indicates that these two processes may not be related. 
Chlorotetracyclines (DMCT and CTC) , the most rapidly pho-
tolyzed compounds, were less phototoxic than doxycycline 
(DOTC) , which was the most potent photosensitizer of the 
series. In this in vitro assay, MC was the least phototoxic of 
the TCs. 
Because the T Cs photodegraded during the phototoxicity 
assay, it is possible that the photodegradation products con· 
tribute to the phototoxicity. Therefore, T C was irradiated with 
UV A in HBSS to >80% conversion. The photoproduct mixtures 
were tested for phototoxicity using UV A radiation , and were 
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TABLE 111. Comparison of PTD50 values for tetracycline and its 
photoproducts 
PTD..,, kJ/m2 , ± SO" 
Compound 
TC'' 
PhTC• 
AHTC' 
Vis ible 
122 ± 30 
55 ± 20 
2.6 ± 0.5 
"Average of at least 2 determinations. 
" [TC material] =' 20 !Lg/ml. 
' )AHTC] =' 4 ILg/ml. 
UYA 
37.0 ± 30 
128.0 ± 40 
33.3 ± 4 
found. to be less phototoxic t han their parent ant ib iotics by at 
least a factor of 2 (Table III). However, when the phototox icity 
experiments were carried out using visible light (380- 600 nm), 
t he photoproducts were about 2 times more potent t han t he 
parent drugs (Table III ). 
We also tested t he phototoxicity to lymphocytes of AHTC, a 
photoproduct of TC under reducing condit ions.* AHTC has an 
absorption maximum at 430 nm and therefore would be ex-
pected to be a better sensitizer when excited at wavelengths 
>400 nm than when UV A excitation is used. When this com-
parison is made, AHTC is about 12 times as potent with visible 
light (380-600 nm) as it is when UV A is used (Table III). 
Oxygen Dependence of T etracycline Phototoxicity 
T he phototoxicity to lymphocytes of TC and DMCT was 
compared in air-satu rated and N1-enriched samples. The PT050 
for t he N2-enriched solut ions is 15-17% higher than that for 
t he air-equilibrated solut ions, suggesti ng that oxygen is in -
volved in the photosensitization process. The possibility that 
singlet oxygen was the reactive species was tested by comparing 
the pbototox icity to lymphocytes in D"O and H zO. The PT0"0 
was determined in 0 20 and H20 with OMCT as the photosen-
sitize r. The PTD5o in 0 20 was 3 t imes lower than in H20 
(FigS). 
DISCUSSION 
Our first approac h to describing t he detailed molecular mech-
an ism of TC-induced phototoxicity was to determine whether 
or not a correlation existed between relative clinical phototox-
icity of a series of TCs and in vitro assays. The two assays 
chosen were: (a) t he relative rates of TC photodegradation, and 
(b) t he relative phototoxicity of TC to human lymphocytes. If 
the relative photodegradation rates refl ected the in vivo pho-
tosensitizing abili ty of t he series, studies to understand the 
molecular photochemistry would be pursued. Likewise, if the 
in vitro assay resu lts paralleled t he in vivo response, further 
studies of t he in vitro phototoxicity mechanism would be ini-
tiated. 
The clinical photosensitizing ability of a ll t he compounds 
used in t his study must be estimated from scattered reports in 
t he lite rature. It is clear that the members of the T C family 
most frequently reported to cause photosensitivity are the 
chloroderivatives, OMCT and CTC [1 -7]. In studies of 
OMCT-, DOTC- and methacycline (MTC) -induced photosen-
sit ivity [3,7]. DMCT produced photosensitivity in 90- 100% of 
the subjects, DOTC in about 20%, and MTC in about 7% . 
T hese variations of in vivo photosensitizing ability with TC 
structures agree with t he t rend in relative photodegradation 
rates we observed (Table II) . However, it appears unlikely that 
t he factor of 1.5 difference (excluding MC) between the most 
rapidly photodegraded compounds (CTC and OMCT) and the 
least (MTC) can totally explain their significant differences in 
photosensitizing ability. When the photolysis was performed 
with BSA present, the rates for CT C and OMCT , but not for 
t he other compounds, were enhanced. This result is consistent 
with a phototoxicity mechanism involving photoreaction of 
TCs with ribosomal proteins. Photoaddit ion of T C to proteins 
of isolated prokaryotic and eukaryotic ribosomes is known 
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FIG 5. Oxygen dependence of photosensitization by DMCT. The 
PBMN cells were treated with DMCT and varying doses of UV A in 
either H20 or D20, and [3H] thymidine incorporation measured for 
every sample. The control in each case was an unirradiated drug-
treated sample of cells. 
[9,10]. Consequently, photochemical change in the presence of 
protein may refl ect the phototoxicity mechanism. 
Comparison of the relative clinical photosensitizing ability 
with t he in vitro PTD50 values from our work does not give a 
strong positive correlation. Consistent with clinical reports, 
CT C and DMCT appear to be more potent in t he in vitro assay 
than the other derivatives except fo r OOTC. In this assay, 
OOTC is the most effective photosensitizer. The high DOTC 
phototoxicity, a lthough unexpected from clinical reports, is in 
agreement with the results of Ljunggren and Moller [17] . These 
workers in their in vivo study of drug phototoxicity by the 
"mouse tail weight method" found DOTC to be twice as potent 
as DMCT. Additional factors such as relative lipophilicity of 
TCs, t heir absorption in t he gut and renal clearance, and t heir 
binding to cellular components and serum proteins must be 
important in determining their photosensitizing ability in vivo. 
For example, von Wittenau and Yeary [18) determined the 
binding of a series of TCs to serum proteins in humans and 
dogs, and determined the relat ive lipophilicity of the series by 
measuring their distribution between chloroform and water. 
Their results show the following order for both lipophilicity 
and binding to human serum proteins: DOTC > DMCT > TC 
> OTC. This is the same order as that observed in our photo-
toxicity assay. 
Our results indicate that there is no quantitative correlation 
between the three aspects of T C phototoxicity discussed above, 
although there appears to be correlation in the general t rend 
(except fo r OOTC). CTC and DMCT photodestruct the fastest, 
are relatively more phototoxic in an in vitro assay, and clinically 
are most frequently cited as photosensitizers. MC is the most 
photostable of the series, is the least phototoxic in vitro, and 
clin ically is not reported to be a photosensitizer. 
The in vivo action spectrum maximum for DMCT appears 
to differ from its absorption maximum. Stratigos and Magnus 
[8] in t heir study on the action spectrum of DMCT found a 
Sept. 1984 
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FIG 6. Schematic representation of the possible effect of PhTC on 
the phototoxic response. 
maximal phototoxic effect at 400 nm. They suggested that this 
maximal phototoxic effect at 400 nm, rather than at the ab-
sorption maximum of DMCT at 375 nm, was due to the greater 
penetration of light through the skin at the longer wavelength. 
This seems unlikely because the absorptivity of the skin is not 
significantly different between 375 and 400 nm [19]. Our re-
sults, depicted in Fig 6, suggest that the variation between 
absorption and action spectrum maxima may be due to the 
intervention of photoproduct(s) that have significant absorp-
t ivity at wavelengths ~ 400 nm (Figs 1, 3). TC photoproducts 
were more phototoxic than the unphotolyzed drug when visible 
radiation was employed. This result may indicate that in vivo 
phototoxicity of TC may be due to at least two main processes: 
(i) photosensitization by the drug of biologic molecules to cause 
phototoxicity; (ii) absorption of light by the drug to yield one 
or more photoproducts. The photoproduct(s) formed then cause 
photosensitization by absorption of visible radiation. We can· 
not, however, exclude possibilities such as formation of a skin-
drug complex which has spectral characteristics that are differ-
ent from those of the drug or photosensitization by a TC 
metabolite which absorbs at wavelengths >400 nm. 
Our results indicated that TC photochemistry was different 
in the presence and absence of oxygeni" and that the in vitro 
phototoxicity was at least partially oxygen-dependent. Singlet 
oxygen may therefore be involved. All of the 7 clinically used 
TCs have previously been shown to photosensit ize oxidation of 
the '02 acceptors, 2,5-dimethylfuran and limonene [20]. That 
oxidation by singlet oxygen may be involved in our in vitro 
lymphocyte phototoxicity assay was indicated by the 3-fold 
increase in the phototoxic effect observed in D20 as compared 
to H 2 0 (Fig 5). The lifetime of singlet oxygen is 4.2 J.LSec in 
H 20 and 55 J.LSeC in n~o [21 ]. Consequently, the rates of singlet 
oxygen -mediated reactions are enhanced in D20 [11] . For such 
reactions, up to a 13-fold increase in photooxidation should, in 
principle, be obtained. However, such large effects will be 
observed on ly if the singlet oxygen relaxes mainly by radiation-
less decay and reacts only with the acceptor molecule. In 
practice, intermediate values are observed [11] . Singlet oxygen 
involvement in TC-induced phototoxicity is further supported 
by recent results of Sandberg et al [22], who demonstrated a 4-
fold enhancement of DOTC-sensitized photodamage to neutro-
phils in D20 as compared to H~O . 
The subcellular site of TC-photosensitized damage is not 
known. The initial signs of TC phototoxicity can appear within 
2 h of UV exposure if the UV dose rates and drug level are high 
[1-7]. A short time between exposure and initial phototoxic 
response is often attributed to membrane damage. Cell mem-
brane damage was also suggested by TC-photosensitized red 
blood cell lysis [11], membrane alteration in bacteria [13], and 
photosensitized changes in lecithin films [23]. Oxygen-depend-
ent mechanisms are often associated with membrane damage 
[24]. However, our results and those in the li terature do not 
exclude other subcellular targets for phototoxicity such as 
DNA, RNA, ribosomal proteins, and mitochondria. It is con-
ceivable that the photodynamic effect represents the oxidative 
t T . Hasan, R.A. Goldman, and B.S. Cooperman, manuscript in 
preparation. 
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damage of these targets, in which case direct drug-target inter-
action is not required. 
In summary, in this initial study on the phototoxicity of TC 
antibiotics we find: (i) there is a general nonquantitative cor-
relation between the clinical phototoxicity, the rates of photo-
chemical degradation , and in vitro phototoxicity; (ii) the pho-
toproduct(s) may contribute to the photosensitizing process 
and may be responsible for the reported differences between 
the in vivo action spectrum and the absorption spectrum of 
DMCT; (iii) the photosensitization is partially oxygen-depend-
ent, and singlet oxygen may be involved. 
We would like to thank Charles Pfizer Co. (Groton, Connecticut) 
and American Cyanamid Company, Lederle Laboratories (Pearl River 
New York) fo r supplying some of the tetracyclines, and Ezra Matzinge; 
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